{"id":71331,"date":"2017-11-08T14:05:06","date_gmt":"2017-11-08T14:05:06","guid":{"rendered":"http:\/\/humanitasnet-new.local\/malattie\/metahromatska-leukodistrofija\/"},"modified":"2025-01-13T02:56:34","modified_gmt":"2025-01-13T02:56:34","slug":"metahromatska-leukodistrofija","status":"publish","type":"disease","link":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/","title":{"rendered":"Metahromatska leukodistrofija"},"content":{"rendered":"<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">Metahromatska leukodistrofija, koja se jo\u0161 naziva i deficijencija Arilsulfataze A, jeste redak genetski poreme\u0107aj i deo ve\u0107e grupe lizozomskih bolesti nakupljanja. Ta\u010dnije, ovaj poreme\u0107aj poga\u0111a rast i\/ili razvoj mijelina koji deluje kao izolator oko nervnih vlakana unutar perifernog i centralnog nervnog sistema. Nedostatak ovog enzima koji poma\u017ee u razgradnji masno\u0107a dovodi do ugradnje lipida u tkivo mozga, ki\u010dmene mo\u017edine i perifernih nerava. Kao rezultat toga, mozak i nervni sistem ubrzano gube svoju funkciju. U retkim slu\u010dajevima, ovo stanje je uzrokovano nedostatkom ne-enzimskog proteina (koji se naziva \u2018aktivator protein\u2019).<\/span><\/p>\n<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">\u00a0<\/span><\/p>\n<h2 id=\"simptomi\"><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">Simptomi<\/span><\/h2>\n<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">Kao i mnogi drugi genetski poreme\u0107aji koji uti\u010du na metabolizam masti, postoji nekoliko oblika MLD-a, koji se mogu preklapati. Me\u0111u njima su:<\/span><\/p>\n<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">Infantilni oblik, koji se javlja kod male dece uzrasta od 6 meseci do 2 godine. Me\u0111u simptomima koji se javljaju su gubitak mi\u0161i\u0107ne mase i slabost, nepokretljivost mi\u0161i\u0107a, zaostanak u razvoju, uznapredovano slabljenje vida koje rezultira slepilom, konvulzije, nepravilno gutanje, paraliza i demencija. Deca mogu da zapadnu u stanje kome. Ukoliko se ne le\u010di, ve\u0107ina dece sa ovim oblikom MLD izgube \u017eivot do 5. godine, neka \u010dak i ranije. <\/span><\/p>\n<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">Juvenilni oblik, javlja se kod dece uzrasta od 3 do 6 godina (rani juvenilni) ili kod dece uzrasta od 6 do 16 godina (kasni juvenilni oblik). Deca obi\u010dno po\u010dinju da ispoljavaju smanjenu aktivnost u \u0161koli, pogor\u0161anje mentalne sposobnosti, i demenciju, da bi se kasnije razvili simptomi sli\u010dni onima kod kasne infantilne forme, ali sa usporenijim napredovanjem toka bolesti. <\/span><\/p>\n<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">Odrasli oblik, pojavljuje se kod osoba od 17 i vi\u0161e godina. Ovaj oblik obi\u010dno se javlja u uzrastu od 16 godina kao psihijatrijski poreme\u0107aj ili progresivna demencija. Odrasli oblik MLD dosta sporije napreduje od infantilnog i juvenilnog oblika, uz produ\u017eeni tok bolesti od jedne decenije ili \u010dak i vi\u0161e. <\/span><\/p>\n<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">\u00a0<\/span><\/p>\n<h2 id=\"uzroci\"><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">Uzroci<\/span><\/h2>\n<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">MLD je direktno uzrokovana nedostatkom enzima Arilsulfataze A (ARSA) i karakteri\u0161e se aktivno\u0161\u0107u enzima u leukocitima koja je ni\u017ea od 10% od normalne kontrolisane vrednosti. Me\u0111utim, test aktivnosti ARSA enzima nije dovoljan za dijagnozu; ARSA pseudo-deficijencija, koja se karakteri\u0161e aktivno\u0161\u0107u koja iznosi 20% od normalne vrednosti ne uzrokuje pojavu MLD. Bez prisustva ovog enzima, sulfatidi kao sastavni deo mnogih tkiva u organizmu, kona\u010dno uni\u0161tavaju mijelinski omota\u010d nervnog sistema.<\/span><\/p>\n<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">\u00a0<\/span><\/p>\n<h2 id=\"faktori-rizika\"><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">Faktori rizika<\/span><\/h2>\n<p><span style=\"font-family: arial,sans-serif; font-size: 10pt;\">Ovaj poreme\u0107aj se nasle\u0111uje putem autosomalnog recesivnog \u0161ablona, \u0161to zna\u010di da obe kopije gena u svakoj od \u0107elija nose mutaciju. Oba roditelja osobe sa autosomalnim recesivnim stanjem nose po jednu kopiju mutiranog gena, ali oni sami nemaju znakove ni simptome ovog poreme\u0107aja.\u00a0 <\/span><\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-71331","disease","type-disease","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Metahromatska leukodistrofija - Humanitas.net<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"sr_RS\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Metahromatska leukodistrofija - Humanitas.net\" \/>\n<meta property=\"og:description\" content=\"Metahromatska leukodistrofija, koja se jo\u0161 naziva i deficijencija Arilsulfataze A, jeste redak genetski poreme\u0107aj i deo ve\u0107e grupe lizozomskih bolesti nakupljanja. Ta\u010dnije, ovaj poreme\u0107aj poga\u0111a rast i\/ili razvoj mijelina koji deluje kao izolator oko nervnih vlakana unutar perifernog i centralnog nervnog sistema. Nedostatak ovog enzima koji poma\u017ee u razgradnji masno\u0107a dovodi do ugradnje lipida u [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/\" \/>\n<meta property=\"og:site_name\" content=\"Humanitas.net\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/HumanitasInternational\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-13T02:56:34+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@humanitasmilano\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/\",\"name\":\"Metahromatska leukodistrofija - Humanitas.net\",\"isPartOf\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#website\"},\"datePublished\":\"2017-11-08T14:05:06+00:00\",\"dateModified\":\"2025-01-13T02:56:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/#breadcrumb\"},\"inLanguage\":\"sr-RS\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/humanitas-net.humweb.webiz.team\/sr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Malattie\",\"item\":\"https:\/\/humanitas-net.humweb.webiz.team\/malattie\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Metahromatska leukodistrofija\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#website\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/\",\"name\":\"Humanitas.net\",\"description\":\"Humanitas Hospital\",\"publisher\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/humanitas-net.humweb.webiz.team\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sr-RS\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#organization\",\"name\":\"Humanitas\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sr-RS\",\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg\",\"contentUrl\":\"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg\",\"width\":1,\"height\":1,\"caption\":\"Humanitas\"},\"image\":{\"@id\":\"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/HumanitasInternational\/\",\"https:\/\/x.com\/humanitasmilano\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Metahromatska leukodistrofija - Humanitas.net","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"sr_RS","og_type":"article","og_title":"Metahromatska leukodistrofija - Humanitas.net","og_description":"Metahromatska leukodistrofija, koja se jo\u0161 naziva i deficijencija Arilsulfataze A, jeste redak genetski poreme\u0107aj i deo ve\u0107e grupe lizozomskih bolesti nakupljanja. Ta\u010dnije, ovaj poreme\u0107aj poga\u0111a rast i\/ili razvoj mijelina koji deluje kao izolator oko nervnih vlakana unutar perifernog i centralnog nervnog sistema. Nedostatak ovog enzima koji poma\u017ee u razgradnji masno\u0107a dovodi do ugradnje lipida u [&hellip;]","og_url":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/","og_site_name":"Humanitas.net","article_publisher":"https:\/\/www.facebook.com\/HumanitasInternational\/","article_modified_time":"2025-01-13T02:56:34+00:00","twitter_card":"summary_large_image","twitter_site":"@humanitasmilano","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/","url":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/","name":"Metahromatska leukodistrofija - Humanitas.net","isPartOf":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#website"},"datePublished":"2017-11-08T14:05:06+00:00","dateModified":"2025-01-13T02:56:34+00:00","breadcrumb":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/#breadcrumb"},"inLanguage":"sr-RS","potentialAction":[{"@type":"ReadAction","target":["https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/diseases\/metahromatska-leukodistrofija\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/"},{"@type":"ListItem","position":2,"name":"Malattie","item":"https:\/\/humanitas-net.humweb.webiz.team\/malattie\/"},{"@type":"ListItem","position":3,"name":"Metahromatska leukodistrofija"}]},{"@type":"WebSite","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#website","url":"https:\/\/humanitas-net.humweb.webiz.team\/","name":"Humanitas.net","description":"Humanitas Hospital","publisher":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/humanitas-net.humweb.webiz.team\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sr-RS"},{"@type":"Organization","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#organization","name":"Humanitas","url":"https:\/\/humanitas-net.humweb.webiz.team\/","logo":{"@type":"ImageObject","inLanguage":"sr-RS","@id":"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/","url":"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg","contentUrl":"https:\/\/humanitas-net.humweb.webiz.team\/wp-content\/uploads\/2025\/01\/new-humanitas-logo-1.svg","width":1,"height":1,"caption":"Humanitas"},"image":{"@id":"https:\/\/humanitas-net.humweb.webiz.team\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/HumanitasInternational\/","https:\/\/x.com\/humanitasmilano"]}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/disease\/71331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/disease"}],"about":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/types\/disease"}],"wp:attachment":[{"href":"https:\/\/humanitas-net.humweb.webiz.team\/sr\/wp-json\/wp\/v2\/media?parent=71331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}